In addition, radiotherapy is frequently used to treat these type of cancers, and recently an abscopal effect after irradiation regimens was described in preclinical models where CD8 T cells were shown to be crucial in improving the response to immunomodulatory monoclonal antibodies, such as anti-PD1 or anti-CD137 [52]. Here, TNFRSF9 is linked to cancer.